CD8A and neoplasm: Consistent with these findings, we observed increased intratumoral CD8+ T cells, and importantly, antitumor CD8+ T cells within the tumor microenvironment after hiFLU or hiFLU-OVA administration (Fig. 2 G and H and SI Appendix, Figs. S6 and S7).